|
IMHO its not just FinHER that is important. N9831 also pointed to an increased benefit of combining herceptin and taxanes. (Thought I'd read something about a ??? synergysitic action of the two but can't find ref at present).
I suppose that at least when the HERA 2 year stats are released, longer term data from the other studies will be available which may help (or indeed hinder) making future plans re studies etc. etc.).
Oh for a "crystal ball" to look at survival data in 10 years time when sorting out treatment plans now.
|
Threaded Mode